214 related articles for article (PubMed ID: 8307506)
21. Atypical sigmoid metastasis from a high-grade mixed adenocarcinoma of the ovary.
Zighelboim I; Broaddus R; Ramirez PT
Gynecol Oncol; 2004 Sep; 94(3):850-3. PubMed ID: 15350388
[TBL] [Abstract][Full Text] [Related]
22. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
[TBL] [Abstract][Full Text] [Related]
23. Coexistence of a mature teratoma and mucinous cystadenocarcinoma in the same ovary--a case report.
Ray S; Anuradha D; Barui G; Karmakar R; Sinha A; Bhattacharya A
Indian J Pathol Microbiol; 2006 Jul; 49(3):420-2. PubMed ID: 17001907
[TBL] [Abstract][Full Text] [Related]
24. Primary peritoneal serous carcinoma presenting as inflammatory breast cancer.
Khalifeh I; Deavers MT; Cristofanilli M; Coleman RL; Malpica A; Gilcrease MZ
Breast J; 2009; 15(2):176-81. PubMed ID: 19292804
[TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological metastases in the ovary].
Pires Y; Andrade L; Cuello M; Chuaqui R
Rev Med Chil; 2002 Nov; 130(11):1232-40. PubMed ID: 12587505
[TBL] [Abstract][Full Text] [Related]
26. Recurrent breast cancer presents as a single solid ovarian mass and ascites.
Chen P; Hu WM; Wang PH; Suen JH
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):356-9. PubMed ID: 17175500
[TBL] [Abstract][Full Text] [Related]
27. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
28. Small cell carcinoma of pulmonary type inside a microinvasive mucinous cystadenocarcinoma of the ovary: a case report.
Grandjean M; Legrand L; Waterkeyn M; Baurain JF; Jadoul P; Donnez J; Marbaix E
Int J Gynecol Pathol; 2007 Oct; 26(4):426-31. PubMed ID: 17885493
[TBL] [Abstract][Full Text] [Related]
29. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
30. Comparison of secondary and primary ovarian malignancies reveals differences in their pre- and perioperative characteristics.
Antila R; Jalkanen J; Heikinheimo O
Gynecol Oncol; 2006 Apr; 101(1):97-101. PubMed ID: 16278010
[TBL] [Abstract][Full Text] [Related]
31. Dedifferentiation in a mucinous tumour of the ovary.
Rekha W; Amita M; Sudeep G; Shubadha K; Hemant T
Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):172. PubMed ID: 15760327
[No Abstract] [Full Text] [Related]
32. [Case of primary infiltrating carcinoma in the right breast with metastatic ovarian dysgerminoma].
Okamoto T; Higaki K; Shinozaki Y; Doi K; Ohtsuki Y
Gan No Rinsho; 1983 Feb; 29(2):A-11, 159-63. PubMed ID: 6876393
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
[TBL] [Abstract][Full Text] [Related]
34. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
Liu C; Zhao Y; Sun X
Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
[TBL] [Abstract][Full Text] [Related]
35. Breast metastasis 56 months before the diagnosis of primary ovarian cancer: a case study.
Schneuber SE; Scholz HS; Regitnig P; Petru E; Winter R
Anticancer Res; 2008; 28(5B):3047-50. PubMed ID: 19031954
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas.
Tuck AB; O'Malley FP; Singhal H; Tonkin KS; Harris JF; Bautista D; Chambers AF
Arch Pathol Lab Med; 1997 Jun; 121(6):578-84. PubMed ID: 9199622
[TBL] [Abstract][Full Text] [Related]
37. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
Leers MP; Hoop JG; Nap M
Anticancer Res; 2003; 23(2A):999-1006. PubMed ID: 12820338
[TBL] [Abstract][Full Text] [Related]
38. Biological indicators of aggressiveness in T1 ductal invasive breast cancer.
Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E
Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792
[TBL] [Abstract][Full Text] [Related]
39. Synchronous serrated adenoma of the appendix and high-grade ovarian carcinoma: a case demonstrating different origin of the two neoplasms.
Rudzki Z; Zazula M; Białas M; Klimek M; Stachura J
Pol J Pathol; 2002; 53(1):29-34. PubMed ID: 12014223
[TBL] [Abstract][Full Text] [Related]
40. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]